Profound Medical (PROF) Total Non-Current Liabilities (2018 - 2026)
Profound Medical's (PROF) quarterly Total Non-Current Liabilities came in at $13.9 million in Q1 2026, up 39.37% year-on-year from $10.0 million in Q1 2025, and up 27.17% quarter-over-quarter from $11.0 million in Q4 2025.
Profound Medical (PROF) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Profound Medical's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $13.9 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 39.37% year-over-year to $13.9 million in Q1 2026; TTM through Mar 2026 was $13.9 million, a 39.37% increase from a year earlier, with the FY2025 full-year figure at $11.0 million, up 12.53% from the prior year.
- Total Non-Current Liabilities rose to $13.9 million in Q1 2026 per PROF's latest filing, from $11.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $13.9 million in Q1 2026 and bottomed at $9.7 million in Q4 2024.
- The 4-year median for Total Non-Current Liabilities is $10.3 million (2025), against an average of $11.1 million.
- Across the five-year window, Total Non-Current Liabilities dropped 23.05% in 2024 and soared 39.37% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $12.7 million in 2023, then declined by 23.05% to $9.7 million in 2024, then grew by 12.53% to $11.0 million in 2025, then rose by 27.17% to $13.9 million in 2026.
- Per Business Quant, the three latest PROF Total Non-Current Liabilities figures stand at $13.9 million (Q1 2026), $11.0 million (Q4 2025), and $10.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.94 Mn |
| Dec 31, 2025 | 10.96 Mn |
| Sep 30, 2025 | 10.09 Mn |
| Jun 30, 2025 | 10.33 Mn |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 9.74 Mn |
| Dec 31, 2023 | 12.66 Mn |
| Dec 31, 2020 | 7.15 Mn |
| Dec 31, 2019 | 15.22 Mn |
| Jan 1, 2019 | 13.87 Mn |
| Dec 31, 2018 | 14.34 Mn |